Provectus
100 year old chemical could be the future of cancer treatment
December 23, 2015Research and Development Cancer, PV-10, Peter Culpepper, Provectus, Rose Bengal, oncology
Peter Culpepper, chief operating officer at Provectus Biopharmaceuticals, explains the secrets of Rose Bengal, which has impressed in clinical trials …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
